Atopic Dermatitis Treatment Market
Market Insights on Atopic Dermatitis Treatment covering sales outlook, demand forecast & up-to-date key trends
Atopic Dermatitis Treatment Market by Product (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Biologic Therapy, PDE-4 Inhibitor, Antibiotics, Antihistamines and Emollients), Mode of administration (Topical, Oral and Injectable) & Region - Forecast 2022 - 2029
Atopic Dermatitis Treatment Market Snapshot
[182 Pages Report] The Global Atopic Dermatitis Treatment Market was valued at US$ 5.2 Bn in 2021 and is expected to reach US$ 7.6 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.
|
Data Points |
Market Insights |
|
Market Value 2021 |
USD 5.2 Bn |
|
Market Value 2029 |
USD 7.6 Bn |
|
CAGR 2022-2029 |
4.8% |
|
Share of Top 5 Countries |
52.1% |
|
Key Players |
The key players in the Atopic Dermatitis Treatment market are Sanofi SA, Galderma SA, Allergan Plc., Novartis, Bristol-Myers Squibb, Bayer AG, Meda Pharmaceuticals, Astellas Pharma Inc., Anacor Pharmaceutical Inc., Regeneron Pharmaceuticals, Valeant Pharmaceutical International Inc. |
Atopic dermatitis is the most common form of eczema, a skin disorder that causes itchy, dry and cracked skin. The rise in prevalence of same has become a worldwide burden for the population. It is at high risk with the patient suffering from asthma and allergic rhinitis as part of an allergic triad that can lead to morbidity.
As a result, the rising prevalence of dermatological skin disorders developed in early childhood and more commonly found as a genetic disorder, are driving up the need for effective atopic dermatitis treatment market. This burdensome disease has increased the focus of manufacturers to develop an effective treatment line for atopic dermatitis at a high demand which in turn has enhanced the atopic dermatitis treatment market.
As there is no such treatment that can cure the atopic dermatitis disorder completely, many alternative treatment lines are available and more are on the horizon. There are currently an unprecedented number of new treatments for eczema in development that has opened up new therapy possibilities with little morbidity. This includes treatments using drugs like cortecosteroids, antibiotics, emollients, biologic therapies etc.
Atopic dermatitis treatment market holds nearly 4.2% of the US$ 124 Bn dermatology drugs and devices market in 2021. There has been significant development in the dermatology treatment space along with the ongoing studies on non-curable atopic dermatitis which provides further guidance for the treatment.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
4.70% |
|
H1, 2022 Projected |
4.80% |
|
H1, 2022 Outlook |
4.69% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 1 ↓ |
The atopic dermatitis treatment market is subject to influence by a rise in patient base with skin disorders, and innovative procedures in accordance with the impact of macro and industry factors. As per the comparative analysis by Future Market Insights for market growth rate in H1 projected and estimated respectively, a decrease in 01 Basis Point Share (BPS) is expected in H1-2022 (O) as compared to H1-2021.
Despite this, the key developments in this market include the introduction of advancements in procedures such as combination therapy with corticosteroids and the mergers of emerging players with established key players to expand their presence in developing regions.
In Asia-Pacific and African regions, the fewer reimbursement policies has been the major reason for the decrease of BPS in the atopic dermatitis market. Hospitals as the end user are expected to perform fairly and attain promising growth prospects in the next half of the projection period. The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 units.
There are some plus points that stay ahead for the industry which include increasing access to medication in developing countries and also R&D to understand the pathogenesis of atopic dermatitis that will lead to the development of systemic treatments.
2014-2021 Market Demand Outlook for Atopic Dermatitis Treatment compared to 2022-2029 Forecast
Skin diseases are the fourth most common cause of human disease, affecting nearly one-third of the population globally. Despite their visibility, global burden due to skin diseases are often undervalued.
Atopic dermatitis (the common form of eczema and a pruritic inflammatory skin condition) is associated with an increased risk of multiple comorbidities, including food allergy, asthma, allergic rhinitis, mental health disorders and itching, as burdensome symptoms of atopic dermatitis.
The demand for atopic dermatitis treatment grew at a CAGR of 4.4% between 2014 and 2021. The rise in cases of eczema or other skin disorder expects to raise the demand for atopic dermatitis treatment.
According to an American College of allergy, asthma & immunology report, Eczema is particularly common in infants, and an estimated 10 to 20 per cent of children are living with it. About 60 per cent of those with eczema will experience symptoms by age 1, and another 30 per cent will experience symptoms by age 5. Children born into families that have a history of allergic diseases such as asthma or hay fever are at an increased risk for developing eczema.
The atopic dermatitis treatment market is expected to grow in the future, as the emergence of the latest technologies in the medical sector and the introduction of innovative procedures are magnifying the demand of this market.
In addition, the market's growth is expected to be boosted by rising acceptance and quick expansion of the novel treatment on the horizon in emerging economies throughout the forecast period. Leading companies are concentrating their efforts on the unveiling of new novel formulations as well as research and development.
For instance, in January 2021, USFDA approved AbbVie's Rinvoq and Pfizer's Cibinqo to treat moderate-to-severe atopic dermatitis, or eczema, in patients unable to respond to the previous treatments or when the use of other treatments are not recommended.
Considering this, FMI expects the global atopic dermatitis treatment market to grow at a CAGR of 4.8% through 2029.
Which Factors Are Restraining the Demand for Atopic Dermatitis Treatment?
Currently, many of the developing and underdeveloped nations lack skin treatment owing to its side effects, high treatment cost, and absence of reimbursement policies in developing countries.
The treatment cost of atopic dermatitis is the main factor restraining the market growth. Based on available evidence, annual paediatric atopic dermatitis costs are generally high. Variations in cost estimates are due to study differences in country of analysis, types of costs included, the severity of atopic dermatitis, and costing methodology.
But generally, the burden of the treatment for atopic dermatitis is borne by the patient mainly in the Asia Pacific and African countries due to the absence of any reimbursement policies in this region.
Additionally, many a times, due to severe atopic conditions, the medications and treatment for atopic dermatitis can be very expensive. For example, Crisaborole costs almost US$ 1,500/patient while the developers of the biologic therapy Dupixent have priced the drug at approximately US$ 37,000/year.
It is uncertain if payers will cover the cost of treatment, considering other lower-cost alternatives. This could hinder the adoption of the drug. However, the scenario is the contrast in few of the developing and underdeveloped economies.
Additionally, corticosteroids have many side effects, dermatologists don’t usually recommend steroids for the treatment of atopic dermatitis. Although oral corticosteroids are approved for the treatment of Atopic Dermatitis, dermatologists do not recommend their use because of rebound on discontinuation.
Dupixent can cause side effects such as serious allergic reactions and eye problems, such as the pink eye (conjunctivitis) and inflammation of the cornea (keratitis). On the other hand, the most common side effects includes cold sores in the mouth or on the lips; injection site reactions; and eye and eyelid inflammation, including swelling, redness, and itching.
Thus all these factors can prove to be a major restraining factor for the drug class segment of the atopic dermatitis treatment market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat is the Impact of the COVID-19 Crisis on the Atopic Dermatitis Treatment Market?
The coronavirus continues to spread over the world, causing chaos in every aspect of people's lives, from how they socialize to how they seek medical treatment and see the world.
The pandemic outbreak has affected every industry in terms of profit or production. However, the atopic dermatitis treatment market has projected a significant impact due to the irregularity of patient’s hospital visits.
The teledermatology has increased during the crisis period, where most of the patients continue to generalize their treatment and or other consulting treatments without physicians meeting.
As per the Nation Eczema Association, during the COVID-19 pandemic, the patients suffering from atopic dermatitis has a higher risk of anxiety and depression and the patients are found to account for increased occurrences in the emergency department.
All these factors are expected to accelerate the growth of atopic dermatitis treatment. However, the market is expected to exhibit a steady recovery and relative increase in future.
Country-wise Insights
What Makes the U.S. a Large Market for Atopic Dermatitis Treatment?
In 2022, U.S. is expected to account for about 90% of the North American atopic dermatitis treatment market. The high frequency and growth in the number of patients suffering from various skin disorders, changes in climatic conditions, and the rise in disposable income, early adoption of novel medications, better reimbursement policies, and increasing business partnerships between the pharmaceutical companies and contract research organizations in the emerging markets, help the lucrative nature of this market in U.S.
For instance, as per the Allergy & Asthma Network research, in the U.S. around 91% of patients experience itching daily, while 15.5% of adolescents with AD report suicidal ideation compared to 9.1% of adolescence. This increases to 23.8% in adolescence living from atopic dermatitis and itching. Although the country deals with high healthcare expenditure, there is an increasing number of campaigns organized each year by certain foundations, such as the PAN Foundation, National Eczema Associations, and several pharmaceutical companies, along with grants.
Why is the U.K. Considered a Lucrative Market for Atopic Dermatitis Treatment?
The U.K. is expected to account for 23.9% of the Western European market in 2022. The country dominates the Western European market owing to the high prevalence of atopic dermatitis among children, increased awareness about atopic dermatitis, favorable medical reimbursement policies and well-established healthcare facilities which are projected to leverage U.K. market share.
According to the National Eczema Society, the most common form, atopic eczema, affects 1 in 5 children and 1 in 10 adults in the UK. The skin is often unbearably itchy – the urge to scratch can be irresistible – and during a flare-up, it can also be red, cracked, sore and raw.
What are the Factors Fueling the Demand for Atopic Dermatitis Treatment in China?
The market for atopic dermatitis treatment in China is projected to grow at a 5.1% CAGR in the Asia Pacific region throughout the forecast period. The rising numbers of CROs and other research organizations which are developing novel medicines and treatment procedures is the major factor that boost the market growth in China.
Along with this, the growing prevalence of eczema among elder population is another major factor for increase in treatment demand. This is because elder patients are more susceptible to having a history of flexion dermatitis to support the course of treatment. According to the WHO, by 2040, the elder population is expected to grow by 28% in China. This will ultimately help boost the atopic dermatitis treatment market in China during the forecast period.
How will the Atopic Dermatitis Treatment market expand across India?
Demand for atopic dermatitis treatment in India is expected to rise at an impressive 5.4% CAGR over the forecast period. The Asian countries have the highest population suffering from atopic dermatitis, along with increasing spending on healthcare, adequate treatment availability, adoption of advanced products, and greater market penetration of new players.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Corticosteroids anticipated continuing Gaining Traction
Based on the drug class, the corticosteroids segment is anticipated to hold the maximum share of 30.9% in 2022, expanding at 5.5% CAGR during the forecast period. Corticosteroids are used as first-line treatment for different diseases, such as skin problems, severe allergies, arthritis, and asthma. Moreover, around 30 corticosteroid compounds have been licensed for atopic dermatitis treatment, of which hydrocortisone is considered to be the first.
Why does the oral route contribute the highest market share by Mode of administration?
In terms of mode of administration, the oral route segment is projected to account for 65.3% of the total market revenue share in 2022. As an oral medication yielded rapid and significant improvements in patients with moderate to severe atopic, it has witnessed higher demand in the atopic dermatitis treatment market.
Which Distribution Channel will be Most Preferred?
By distribution channel, hospital pharmacies and retail pharmacies together hold over 42% of the market in 2021 and this trend is expected to continue during the forecast period as well. Easy availability of therapeutic drugs, affordability and convenience are some of the factors boosting the growth of the atopic dermatitis treatment market.
Competitive Landscape
Companies in the atopic dermatitis treatment market are pursuing new product innovation and launches, regulatory approvals and company expansions as the key strategies.
Key players are relying heavily on advertising expenses and branding strategies. They are also focusing on mergers and collaborative agreements with the leading players and taking initiatives for promoting their product at an international platform. The key players are also focusing on the development of novel and cost-effective treatment lines to provide solutions for the unmet needs. Along with this, the players are establishing joint agreements to develop a novel treatment and increase geographic reach by targeting Asian region by way of establishing manufacturing units to reduce manufacturing costs. For instance:
- In June 2021, Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin's potential first-in-class, Phase 3-ready anti-OX40 fully human monoclonal antibody in development for the treatment of atopic dermatitis, with potential in other autoimmune diseases. Under terms of the agreement, Amgen will lead the development, manufacturing, and commercialization for KHK4083 for all markets globally, except Japan, where Kyowa Kirin will retain all rights.
- In February 2021, the USFDA agreed to the Priority Review of New Drug Application (NDA) for ruxolitinib cream developed by Incyte Corporation. It is a selective JAK1/JAK2 inhibitor used for topical application, as a treatment for atopic dermatitis (AD), a type of eczema.
- In May 2020, Sanofi received the U.S.FDA approval for its Dupixent (dupilumab), the first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2022-2029 |
|
Historical Data Available for |
2014-2021 |
|
Market Analysis |
USD Million for Value |
|
Key Regions Covered |
North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Poland, Russia, France, U.K., Germany, Spain, Italy, BENELUX, Nordic, China, India, Australia and New Zealand, ASEAN, GCC Countries, Turkey, North Africa and South Africa |
|
Key Segments Covered |
Drugs, Mode of Administration, Distribution Channel and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Atopic Dermatitis Treatment Market by Category
By Product
- Corticosteroids
- Calcineurin Inhibitors
- Immunosuppressants
- Biologic Therapy
- PDE-4 Inhibitor
- Antibiotics
- Antihistamines
- Emollients
By Indication
- Topical
- Oral
- Injectable
By End-User
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Mail Order Pharmacies
- Dermatology Clinics
By Region
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan
- Japan
- Middle East and Africa (MEA)
Frequently Asked Questions
The Global atopic dermatitis treatment market is worth US$ 5.2 Bn in 2021 and is set to expand 1.4X over the next seven years.
The atopic dermatitis treatment market is expected to reach US$ 7.6 Bn by the end of 2029, with sales revenue expected to grow at a 4.8% CAGR.
The global market for atopic dermatitis treatment is projected to reflect high demand in the forecast period with a CAGR of 4.8% owing to the rising prevalence of skin disease and increasing government and private body initiatives to grow awareness for skin diseases, and early treatment.
North America currently holds the largest market share of around 30.7% of the global atopic dermatitis treatment market with the U.S. being the leading contributor with a market value of around US$ 1.4 Bn in 2021.
The atopic dermatitis treatment market in India is likely to grow at a CAGR of 5.4% during the forecast period, with a market share of around 28.7% in 2021 of the Asia Pacific Market for atopic dermatitis treatment. The rise in research and development activities in India, and growing awareness among the population are responsible for the growth of the atopic dermatitis treatment market in India.
Focus towards systemic agents over the orally administered drugs in terms of its bioavailability, mergers and acquisitions among the players in order to strengthen the market positions and development of novel drugs are the major key trends in the atopic dermatitis treatment market.
Japan’s market in atopic dermatitis treatment is offering lucrative growth opportunities and is expected to exhibit healthy growth of 5.1% CAGR during the forecast period.
U.S., Japan, Russia, the UK, and France are the top 5 countries that are driving the demand for atopic dermatitis treatment.
Leading companies of atopic dermatitis treatment are Sanofi SA, Galderma SA, Allergan Plc., Novartis, Bristol-Myers Squibb, Bayer AG, Meda Pharmaceuticals, Astellas Pharma Inc., Anacor Pharmaceutical Inc., Regeneron Pharmaceuticals, and Valeant Pharmaceutical International Inc.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
2.3. Parent Market Overview
3. Atopic Dermatitis Treatment Market Scenario
3.1. Global Atopic Dermatitis Treatment Market Size (US$ Mn) and Forecast
4. Atopic Dermatitis Treatment Market Opportunity Analysis
4.1. Global Epidemiology of Atopic Dermatitis
4.2. Global Atopic Dermatitis Treatment Market Opportunity Analysis
4.3. Atopic Dermatitis Treatment Market: Key Regulations and Guidelines
5. North America Atopic Dermatitis Treatment Market Analysis and Forecast
5.1. Regional Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.2. North America Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Country
5.2.1. US
5.2.2. Canada
5.3. North America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029
5.3.1. US
5.3.2. Canada
5.4. North America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
5.4.1. Corticosteroids
5.4.2. Calcineurin Inhibitors
5.4.3. Immunosuppressants
5.4.4. Biologic Therapy
5.4.5. PDE-4 Inhibitor
5.4.6. Antibiotics
5.4.7. Antihistamines
5.4.8. Emollients
5.5. North America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
5.5.1. Topical
5.5.2. Oral
5.5.3. Injectable
5.6. North America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
5.6.1. Hospital Pharmacies
5.6.2. Retail Pharmacies
5.6.3. Online Pharmacies
5.6.4. Drug Stores
5.6.5. Mail Order Pharmacies
5.6.6. Dermatology Clinics
5.7. North America Atopic Dermatitis Treatment Market Attractiveness Analysis, 2022–2029
6. Western Europe Atopic Dermatitis Treatment Market Analysis and Forecast
6.1. Regional Market Dynamics
6.1.1. Drivers
6.1.2. Restraints
6.2. Western Europe Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Country
6.2.1. France
6.2.2. Germany
6.2.3. UK
6.2.4. Spain
6.2.5. Italy
6.2.6. Benelux
6.2.7. Nordic
6.2.8. Rest of Western Europe
6.3. Western Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029
6.3.1. France
6.3.2. Germany
6.3.3. UK
6.3.4. Spain
6.3.5. Italy
6.3.6. Benelux
6.3.7. Nordic
6.3.8. Rest of Western Europe
6.4. Western Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
6.4.1. Corticosteroids
6.4.2. Calcineurin Inhibitors
6.4.3. Immunosuppressants
6.4.4. Biologic Therapy
6.4.5. PDE-4 Inhibitor
6.4.6. Antibiotics
6.4.7. Antihistamines
6.4.8. Emollients
6.5. Western Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
6.5.1. Topical
6.5.2. Oral
6.5.3. Injectable
6.6. Western Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
6.6.1. Hospital Pharmacies
6.6.2. Retail Pharmacies
6.6.3. Online Pharmacies
6.6.4. Drug Stores
6.6.5. Mail Order Pharmacies
6.6.6. Dermatology Clinics
6.7. Western Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, 2022–2029
7. Eastern Europe Atopic Dermatitis Treatment Market Analysis and Forecast
7.1. Regional Market Dynamics
7.1.1. Drivers
7.1.2. Restraints
7.2. Eastern Europe Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Country
7.2.1. Russia
7.2.2. Poland
7.3. Eastern Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Eastern Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
7.4.1. Corticosteroids
7.4.2. Calcineurin Inhibitors
7.4.3. Immunosuppressants
7.4.4. Biologic Therapy
7.4.5. PDE-4 Inhibitor
7.4.6. Antibiotics
7.4.7. Antihistamines
7.4.8. Emollients
7.5. Eastern Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
7.5.1. Topical
7.5.2. Oral
7.5.3. Injectable
7.6. Eastern Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
7.6.1. Hospital Pharmacies
7.6.2. Retail Pharmacies
7.6.3. Online Pharmacies
7.6.4. Drug Stores
7.6.5. Mail Order Pharmacies
7.6.6. Dermatology Clinics
7.7. Eastern Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, 2022–2029
8. APEJ Atopic Dermatitis Treatment Market Analysis and Forecast
8.1. Regional Market Dynamics
8.1.1. Drivers
8.1.2. Restraints
8.2. APEJ Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Country
8.2.1. China
8.2.2. India
8.2.3. ASEAN
8.2.4. Australia and New Zealand
8.2.5. Rest of APEJ
8.3. APEJ Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029
8.3.1. China
8.3.2. India
8.3.3. ASEAN
8.3.4. Australia and New Zealand
8.3.5. Rest of APEJ
8.4. APEJ Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
8.4.1. Corticosteroids
8.4.2. Calcineurin Inhibitors
8.4.3. Immunosuppressants
8.4.4. Biologic Therapy
8.4.5. PDE-4 Inhibitor
8.4.6. Antibiotics
8.4.7. Antihistamines
8.4.8. Emollients
8.5. APEJ Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
8.5.1. Topical
8.5.2. Oral
8.5.3. Injectable
8.6. APEJ Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
8.6.1. Hospital Pharmacies
8.6.2. Retail Pharmacies
8.6.3. Online Pharmacies
8.6.4. Drug Stores
8.6.5. Mail Order Pharmacies
8.6.6. Dermatology Clinics
8.7. APEJ Atopic Dermatitis Treatment Market Attractiveness Analysis, 2022–2029
9. Latin America Atopic Dermatitis Treatment Market Analysis and Forecast
9.1. Regional Market Dynamics
9.1.1. Drivers
9.1.2. Restraints
9.2. LA Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of LA
9.3. LA Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029
9.3.1. Brazil
9.3.2. Mexico
9.3.3. Rest of LA
9.4. LA Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
9.4.1. Corticosteroids
9.4.2. Calcineurin Inhibitors
9.4.3. Immunosuppressants
9.4.4. Biologic Therapy
9.4.5. PDE-4 Inhibitor
9.4.6. Antibiotics
9.4.7. Antihistamines
9.4.8. Emollients
9.5. LA Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
9.5.1. Topical
9.5.2. Oral
9.5.3. Injectable
9.6. LA Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
9.6.1. Hospital Pharmacies
9.6.2. Retail Pharmacies
9.6.3. Online Pharmacies
9.6.4. Drug Stores
9.6.5. Mail Order Pharmacies
9.6.6. Dermatology Clinics
9.7. LA Atopic Dermatitis Treatment Market Attractiveness Analysis, 2022–2029
10. Middle East & Africa Atopic Dermatitis Treatment Market Analysis and Forecast
10.1. Regional Market Dynamics
10.1.1. Drivers
10.1.2. Restraints
10.2. MEA Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Country
10.2.1. GCC Countries
10.2.2. Turkey
10.2.3. North Africa
10.2.4. South Africa
10.2.5. Rest of MEA
10.3. MEA Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029
10.3.1. GCC Countries
10.3.2. Turkey
10.3.3. North Africa
10.3.4. South Africa
10.3.5. Rest of MEA
10.4. MEA Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
10.4.1. Corticosteroids
10.4.2. Calcineurin Inhibitors
10.4.3. Immunosuppressants
10.4.4. Biologic Therapy
10.4.5. PDE-4 Inhibitor
10.4.6. Antibiotics
10.4.7. Antihistamines
10.4.8. Emollients
10.5. MEA Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
10.5.1. Topical
10.5.2. Oral
10.5.3. Injectable
10.6. MEA Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
10.6.1. Hospital Pharmacies
10.6.2. Retail Pharmacies
10.6.3. Online Pharmacies
10.6.4. Drug Stores
10.6.5. Mail Order Pharmacies
10.6.6. Dermatology Clinics
10.7. MEA Atopic Dermatitis Treatment Market Attractiveness Analysis, 2022–2029
11. Japan Atopic Dermatitis Treatment Market Analysis and Forecast
11.1. Regional Market Dynamics
11.1.1. Drivers
11.1.2. Restraints
11.2. Japan Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Country
11.3. Japan Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029
11.4. Japan Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
11.4.1. Corticosteroids
11.4.2. Calcineurin Inhibitors
11.4.3. Immunosuppressants
11.4.4. Biologic Therapy
11.4.5. PDE-4 Inhibitor
11.4.6. Antibiotics
11.4.7. Antihistamines
11.4.8. Emollients
11.5. Japan Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
11.5.1. Topical
11.5.2. Oral
11.5.3. Injectable
11.6. Japan Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
11.6.1. Hospital Pharmacies
11.6.2. Retail Pharmacies
11.6.3. Retail Pharmacies
11.6.4. Online Pharmacies
11.6.5. Drug Stores
11.6.6. Mail Order Pharmacies
11.6.7. Dermatology Clinics
11.7. Japan Atopic Dermatitis Treatment Market Attractiveness Analysis, 2022–2029
12. Forecast Factors: Relevance and Impact
13. Forecast Assumptions
14. Competition Landscape
14.1. Sanofi SA
14.2. Galderma SA
14.3. Allergan Plc.
14.4. Novartis
14.5. Bristol-Myers Squibb
14.6. Bayer AG
14.7. Meda Pharmaceuticals
14.8. Astellas Pharma Inc.
14.9. Anacor Pharmaceutical Inc.
14.10. Regeneron Pharmaceuticals
14.11. Valeant Pharmaceuticals Int. Inc.
15. Global Atopic Dermatitis Treatment Market Analysis 2014–2021 and Forecast 2022–2029, By Region
15.1. Global Atopic Dermatitis Treatment Market: Opportunities
15.2. Global Atopic Dermatitis Treatment Market: Trends
15.3. Global Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Region, 2022–2029
15.4. Global Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Region
15.5. Global Atopic Dermatitis Treatment Market Attractiveness Analysis, By Region
16. Global Atopic Dermatitis Treatment Market Analysis 2014–2021 and Forecast 2022–2029, By Drug Type
16.1. Global Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Drug Type, 2022–2029
16.2. Global Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Type
16.3. Global Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Type
17. Global Atopic Dermatitis Treatment Market Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
17.1. Global Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Mode of Administration, 2022–2029
17.2. Global Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
17.3. Global Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
18. Global Atopic Dermatitis Treatment Market Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
18.1. Global Atopic Dermatitis Treatment Market BPS Analysis & Y-o-Y Growth By Distribution Channel, 2022–2029
18.2. Global Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
18.3. Global Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
19. Forecast Assumptions
20. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: North America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Country
Table 02: North America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
Table 03: North America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
Table 04: North America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
Table 05: Western Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Country
Table 06: Western Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
Table 07: Western Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
Table 08: Western Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
Table 09: Eastern Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Country
Table 10: Eastern Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
Table 11: Eastern Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
Table 12: Eastern Europe Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
Table 13: APEJ Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Country
Table 14: APEJ Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
Table 15: APEJ Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
Table 16: APEJ Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
Table 17: Latin America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Country
Table 19: Latin America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
Table 20: Latin America Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
Table 21: Middle East & Africa Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Country
Table 22: Middle East & Africa Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
Table 23: Middle East & Africa Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
Table 24: Middle East & Africa Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
Table 25: Japan Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Class
Table 26: Japan Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
Table 27: Japan Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
Table 28: Global Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Region
Table 29: Global Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Drug Type
Table 30: Global Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Mode of Administration
Table 31: Global Atopic Dermatitis Treatment Market Size (US$ Mn) Trend Analysis 2014–2021 and Forecast 2022–2029, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: North America Atopic Dermatitis Treatment Market Share Analysis (%) By Country, 2022 & 2029
Figure 02: North America Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Country, 2021–2029
Figure 03: North America Atopic Dermatitis Treatment Market Size Analysis, 2014–2021
Figure 04: North America Atopic Dermatitis Treatment Market Forecast, 2022–2029
Figure 05: North America Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country
Figure 06: North America Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class
Figure 07: North America Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
Figure 08: North America Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 09: Western Europe Atopic Dermatitis Treatment Market Share Analysis (%) By Country, 2022 & 2029
Figure 10: Western Europe Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Country, 2021–2029
Figure 11: Western Europe Atopic Dermatitis Treatment Market Size Analysis, 2014–2021
Figure 12: Western Europe Atopic Dermatitis Treatment Market Forecast, 2022–2029
Figure 13: Western Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country
Figure 14: Western Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class
Figure 15: Western Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
Figure 16: Western Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 17: Eastern Europe Atopic Dermatitis Treatment Market Share Analysis (%) By Country, 2022 & 2029
Figure 18: Eastern Europe Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Country, 2022–2029
Figure 19: Eastern Europe Atopic Dermatitis Treatment Market Size Analysis, 2014–2021
Figure 20: Eastern Europe Atopic Dermatitis Treatment Market Forecast, 2022–2029
Figure 21: Eastern Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country
Figure 22: Eastern Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class
Figure 23: Eastern Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
Figure 24: Eastern Europe Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 25: APEJ Atopic Dermatitis Treatment Market Share Analysis (%) By Country, 2022 & 2029
Figure 26: APEJ Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Country, 2021–2029
Figure 27: APEJ Atopic Dermatitis Treatment Market Size Analysis, 2014–2021
Figure 28: APEJ Atopic Dermatitis Treatment Market Forecast, 2022–2029
Figure 29: APEJ Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country
Figure 30: APEJ Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class
Figure 31: APEJ Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
Figure 32: APEJ Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 33: Latin America Atopic Dermatitis Treatment Market Share Analysis (%) By Country, 2022 & 2029
Figure 34: Latin America Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Country, 2021–2029
Figure 35: Latin America Atopic Dermatitis Treatment Market Size Analysis, 2014–2021
Figure 36: Latin America Atopic Dermatitis Treatment Market Forecast, 2022–2029
Figure 37: Latin America Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country
Figure 38: Latin America Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class
Figure 39: Latin America Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
Figure 40: Latin America Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 41: Middle East & Africa Atopic Dermatitis Treatment Market Share Analysis (%) By Country, 2022 & 2029
Figure 42: Middle East & Africa Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Country, 2021–2029
Figure 43: Middle East & Africa Atopic Dermatitis Treatment Market Size Analysis, 2014–2021
Figure 44: Middle East & Africa Atopic Dermatitis Treatment Market Forecast, 2022–2029
Figure 45: Middle East & Africa Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country
Figure 46: Middle East & Africa Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class
Figure 47: Middle East & Africa Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
Figure 48: Middle East & Africa Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 49: Japan Atopic Dermatitis Treatment Market Size Analysis, 2014–2021
Figure 50: Japan Atopic Dermatitis Treatment Market Forecast, 2022–2029
Figure 51: Japan Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
Figure 52: Japan Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 53: Japan Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class
Figure 54: Global Atopic Dermatitis Treatment Market Share Analysis (%) By Region, 2022 & 2029
Figure 55: Global Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Region, 2021–2029
Figure 56: Global Atopic Dermatitis Treatment Market Attractiveness Analysis, By Region
Figure 57: Global Atopic Dermatitis Treatment Market Share Analysis (%) By Drug Type, 2022 & 2029
Figure 58: Global Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Drug Type, 2021–2029
Figure 59: Global Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Type
Figure 60: Global Atopic Dermatitis Treatment Market Share Analysis (%) By Mode of Administration, 2022 & 2029
Figure 61: Global Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Mode of Administration, 2021–2029
Figure 62: Global Atopic Dermatitis Treatment Market Attractiveness Analysis, By Mode of Administration
Figure 63: Global Atopic Dermatitis Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2029
Figure 64: Global Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2021–2029
Figure 65: Global Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
